Canaccord Genuity reiterated coverage on Rezolute with a new price target

11/29/21 8:15:56 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Canaccord Genuity reiterated coverage of Rezolute with a rating of Buy and set a new price target of $17.00 from $30.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$RZLT

Date	Price Target	Rating	Analyst
11/5/2024	$12.00	Outperform	Wedbush
8/27/2024	$11.00	Buy	Guggenheim
7/17/2024	$13.00	Buy	BTIG Research
6/4/2024	$14.00	Buy	Craig Hallum
4/9/2024	$8.00	Buy	Maxim Group
8/2/2022	$17.00	Buy	Canaccord Genuity
6/15/2022	$9.00	Overweight	Cantor Fitzgerald
11/29/2021	$30.00 → $17.00	Buy	Canaccord Genuity